HEMATOLOGIC NEOPLASMS
Clinical trials for HEMATOLOGIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC NEOPLASMS trials appear
Sign up with your email to follow new studies for HEMATOLOGIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a lower drug dose make stem cell transplants safer for blood cancer patients?
Disease control OngoingThis study looks at whether a lower dose of the drug cyclophosphamide, given after a stem cell transplant, can prevent complications like graft-versus-host disease (GVHD) while still controlling blood cancers. About 105 people aged 15-65 with leukemia, lymphoma, or multiple myelo…
Matched conditions: HEMATOLOGIC NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 03:18 UTC
-
Could dropping one drug make stem cell transplants safer and simpler?
Disease control OngoingThis study looks at whether it is safe to skip one immune-suppressing drug (MMF) after a stem cell transplant for blood cancers. About 60 adults will receive the standard transplant and then take only two drugs (cyclophosphamide and tacrolimus) instead of the usual three. The goa…
Matched conditions: HEMATOLOGIC NEOPLASMS
Phase: PHASE2 • Sponsor: Ronald Paquette • Aim: Disease control
Last updated May 14, 2026 12:03 UTC